Clinical Trials Directory

Trials / Unknown

UnknownNCT05929534

pBFS-guided iTBS Over the Superior Temporal Gyrus for Aphasia After Ischemic Stroke

Personalized Brain Functional Sector-guided Intermittent Theta Burst Stimulation Therapy Targeting at the Superior Temporal Gyrus for Aphasia After Ischemic Stroke: a RCT

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Changping Laboratory · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this trial is to evaluate the effectiveness and safeness of intermittent Theta Burst Stimulation (iTBS) over the left Superior Temporal Gyrus (STG), guided by personalized Brain Functional Sector (pBFS) technology, on language function recovery in patients with post-ischemic stroke aphasia.

Detailed description

Increasing evidence suggests that rTMS has been effective in treating various psychological and neurological diseases, including treating post-stroke symptoms. Using the personalized Brain Functional Sector (pBFS) technique, investigators could precisely identify individualized brain functional networks and the personalized language-related stimulation site based on the resting-state functional MRI data. The current study proposes to conduct a double-blinded, randomized and sham controlled trial, to investigate the efficacy and safety of pBFS-guided personalized rTMS intervention in post-stroke aphasic patients. Subjects will be randomly assigned to the following two groups: active intermittent TBS (iTBS) group, or a sham control group. The allocation ratio will be 1:1. The stimulation protocol consists of a 3-week treatment, with five consecutive days each week (totally 15 day-treatment) . The stimulation procedure will be assisted with real-time neuronavigation to ensure its precision.

Conditions

Interventions

TypeNameDescription
DEVICEactive intermittent Theta Burst StimulationEach patient will receive two 600-pulse iTBS stimulations per day, parted by a 15-minute rest period (a total of 1200 pulses daily), for 3-week treatment, with five consecutive days each week.
DEVICEsham intermittent Theta Burst StimulationEach patient will receive two sham 600-pulse iTBS stimulations per day, parted by a 15-minute rest period (a total of 1200 pulses daily), for 3-week treatment, with five consecutive days each week.

Timeline

Start date
2023-07-01
Primary completion
2024-06-30
Completion
2025-06-30
First posted
2023-07-03
Last updated
2023-07-10

Source: ClinicalTrials.gov record NCT05929534. Inclusion in this directory is not an endorsement.